🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eleftheria Kampouri

Centre Hospitalier Universitaire Vaudois

ORCID: 0000-0001-8019-3073
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy”.

Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy

Clinical Infectious Diseases(2023)10.1093/cid/ciad708
N/A
0DataRank · unranked
52 citations

Sarah Ibrahimi, Hu Xie, Elizabeth R Wong, Jessica Hecht, Mandeep K Sekhon +11 more

Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis

Clinical Microbiology and Infection(2023)10.1016/j.cmi.2023.07.026
N/A
0DataRank · unranked
14 citations

Danniel Zamora, Erika S. Kiem, Winnie Liu, Sarah Ibrahimi, Rachel Blazevic +11 more

Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients

Blood(2024)10.1182/blood.2024024145
N/A
0DataRank · unranked
19 citations

Elizabeth M. Krantz, Hu Xie, Sarah Ibrahimi, Erika S. Kiem, Mandeep K Sekhon +13 more

CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation

Blood Advances(2024)10.1182/bloodadvances.2023012234
N/A
0DataRank · unranked
15 citations

Hu Xie, Alicja Sadowska‐Klasa, Eleftheria Kampouri, Melinda A. Biernacki, Masumi Ueda +12 more

Understanding the Clinical Significance of Cytomegalovirus Viremia After Chimeric Antigen Receptor T-Cell Therapy: Should We be Treating a Value?

Clinical Infectious Diseases(2024)10.1093/cid/ciae030
N/A
0DataRank · unranked
5 citations

Michael J Boeckh, Joshua A. Hill, Eleftheria Kampouri

ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients

Bone Marrow Transplantation(2025)10.1038/s41409-025-02611-4
N/A
0DataRank · unranked
7 citations

Hu Xie, Elizabeth Wong, Clarissa Santiano, Andrea Vivas-Jimenez, Alicja Sadowska‐Klasa +7 more

American Society for Transplantation and Cellular Therapy Series #9: Management of Human Herpesvirus 6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T-Cell Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.05.001
N/A
0DataRank · unranked
6 citations

Guy Handley, Tuan L. Phan, Yeon Joo Lee, Ryan Shaw, Paul A. Carpenter +8 more

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy

Blood Advances(2025)10.1182/bloodadvances.2024015164
N/A
0DataRank · unranked
5 citations

Patrick W Flaherty, Hu Xie, Mandeep K Sekhon, Clementine Chalal, Terry Stevens‐Ayers +9 more